Genxai Analytics IPO GMP Day 1 on 5 June 2026: Rs 8 Grey Market Premium Signals 6.9% Expected Listing Gain on NSE SME
- June 5, 2026
- Posted by: Ankit Jaiswal
- Category: IPO
Genxai Analytics IPO GMP Day 1 (June 5): Rs 8/share. Expected listing Rs 124 (+6.9%). Price Rs 110-116. Issue size Rs 54.84 Cr. Close Jun 9. Listing Jun 12 NSE SME.
The Genxai Analytics IPO GMP is grabbing the attention of IPO investors on 5 June 2026, as the Day 1 of the public issue shows Day 1 activity building as retail investors begin applying.
Genxai Analytics Limited, incorporated in 2007 and headquartered in India, is a technology-driven enterprise performance and analytics solutions company. The Genxai Analytics IPO is backed by a business that offers AI-enabled workflow and analytics platforms including enterprise planning (EPM), data engineering, analytics, cloud solutions, application development, and Generative AI solutions. The company integrates data across finance, sales, operations, customer management, and human resources into unified systems that enable data-driven decision-making. As of March 2026, the company had 362 permanent employees, with the majority in technology and delivery roles.
The grey market premium (GMP) for Genxai Analytics IPO GMP is currently Rs 8 per share, indicating an expected listing price of approximately Rs 124 against the upper price band of Rs 110 to Rs 116 per share per share, implying a potential listing gain of approximately 6.9%.
Investors must note that grey market premium is an unofficial, unregulated indicator that is not governed by SEBI. GMP fluctuates daily based on investor sentiment, subscription data, and broader market conditions. The Genxai Analytics IPO GMP grey market premium should be used as one data point. Investors tracking the Genxai Analytics IPO GMP among many in the investment decision process, not as the primary factor. Investors should review the full prospectus before applying for the Genxai Analytics IPO GMP. This does not constitute investment advice.
Click Here – Get Free Investment Predictions
Genxai Analytics IPO GMP: Key IPO Details on 5 June 2026
| Parameter | Details |
|---|---|
| Company | Genxai Analytics Limited |
| Issue Type | Book-built, Fresh Issue (no OFS) |
| Exchange | NSE SME (NSE Emerge) |
| Issue Size | Rs 54.84 crore |
| Price Band / Issue Price | Rs 110 to Rs 116 per share |
| Face Value | Rs 10 per share |
| Lot Size | 1,200 shares (minimum 2 lots = 2,400 shares for retail) |
| Minimum Investment | Rs 2,78,400 (retail, 2 lots at upper price band) |
| Open Date | June 5, 2026 |
| Close Date | June 9, 2026 |
| Allotment Date | June 10, 2026 |
| Listing Date | June 12, 2026 (NSE SME) |
| Issue Structure | 100% Fresh Issue of 47.28 lakh equity shares |
| Book Running Lead Manager | Choice Capital Advisors Pvt Ltd |
| Registrar | Bigshare Services Pvt Ltd |
| GMP (5 June 2026) | Rs 8 per share |
| Expected Listing Price | ~Rs 124 |
| Expected Listing Gain | ~6.9% above issue price |
Check Live IPO Subscription and Allotment on Univest
Track all open IPOs, subscription rates, GMP trends and allotment status in real time.
- Live GMP and subscription data for all open IPOs
- Allotment status checker and listing day alerts
- IPO research and expert analysis on every issue
Access IPO research and insights on Univest
What Is Genxai Analytics Limited and What Does It Do?
Genxai Analytics Limited, incorporated in 2007 and headquartered in India, is a technology-driven enterprise performance and analytics solutions company. The Genxai Analytics IPO is backed by a business that offers AI-enabled workflow and analytics platforms including enterprise planning (EPM), data engineering, analytics, cloud solutions, application development, and Generative AI solutions. The company integrates data across finance, sales, operations, customer management, and human resources into unified systems that enable data-driven decision-making. As of March 2026, the company had 362 permanent employees, with the majority in technology and delivery roles.
Genxai Analytics IPO GMP: Financial Performance
The Genxai Analytics IPO is backed by a company with growing financials. The largest allocation of IPO proceeds is Rs 28.37 crore toward capital expenditure for development of new products, reflecting the company’s intent to deepen its AI and analytics product portfolio. Working capital requirements of Rs 6 crore and repayment of borrowings of Rs 2.50 crore make up the remaining significant allocations, with the balance toward general corporate purposes. Anchor investors were allocated shares worth Rs 14.99 crore on June 4, 2026, indicating institutional interest in the Genxai Analytics IPO ahead of Day 1 retail subscription. Investors should refer to the Red Herring Prospectus (RHP) for complete FY26 financial data.
Genxai Analytics IPO GMP: Use of IPO Proceeds
The Genxai Analytics IPO proceeds will be used as follows: Rs 28.37 crore for capital expenditure toward new product development; Rs 6 crore for working capital requirements; Rs 2.50 crore for repayment of outstanding borrowings; and the balance for general corporate purposes. Since the Genxai Analytics IPO is a 100% fresh issue with no offer-for-sale component, all proceeds will flow to the company. This is generally considered investor-friendly as it means promoters are not exiting at the IPO stage.
Genxai Analytics IPO GMP: Promoters and Shareholding
The Genxai Analytics IPO is promoted by Rakesh Agarwal and Lakshmi Agarwal, who together held approximately 90.28% of the company’s equity before the IPO. Post-listing, promoter holding will reduce as public shareholders take up the 47.28 lakh fresh shares. The high pre-IPO promoter holding of 90.28% means significant equity concentration remains with the founders post-listing, which is common for SME IPOs but means the free float will be relatively thin, potentially causing higher price volatility on listing day.
Key Risks to the Genxai Analytics IPO GMP
Key risks to the Genxai Analytics IPO include: the SME IPO segment’s inherent lower liquidity compared to mainboard issues; thin free float post-listing given high promoter holding; concentration in enterprise IT which faces competition from global and domestic players; revenue concentration risk if a few large clients contribute disproportionate revenue; and execution risk on the product development capex of Rs 28.37 crore, which is the largest use of proceeds. The Genxai Analytics IPO GMP of Rs 8 is relatively modest, suggesting the market does not yet have high conviction in a bumper listing. Investors should review the complete risk factors in the RHP before applying. This does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track Genxai Analytics IPO GMP GMP updates, subscription data and listing alerts.
Should You Apply for the Genxai Analytics IPO GMP?
The decision to apply for the Genxai Analytics IPO GMP should be based on a thorough review of the company’s financials, business model, valuation, and risk factors as disclosed in the Red Herring Prospectus. The Genxai Analytics IPO GMP of Rs 8 provides some indication of grey market sentiment, but GMP is unofficial and can change rapidly. Investors should evaluate the Genxai Analytics IPO GMP valuation against listed peers, assess the promoter track record, and consider whether the business has durable competitive advantages before applying. This article is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decision related to the Genxai Analytics IPO GMP.
Conclusion
The Genxai Analytics IPO GMP on 5 June 2026 is in its day 1 with subscription data and a GMP of Rs 8 (expected listing gain ~6.9%). The Genxai Analytics IPO GMP issue closes on June 9, 2026, with allotment expected on June 10, 2026 and listing on June 12, 2026 (NSE SME). Investors should review the Genxai Analytics IPO GMP prospectus, compare the valuation with listed peers, and make an informed decision based on their own risk appetite and investment horizon. This does not constitute investment advice.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Disclaimer: The securities quoted, if any, are for illustration purposes only and are not recommendatory. This article is for educational purposes only and shall not be considered as investment advice or a recommendation by Univest (Uniresearch Global Pvt Ltd, SEBI Registered Research Analyst INH000013776). Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI in no way guarantees the performance of the intermediary or provides any assurance of returns to investors. Past performance is not indicative of future results.
Frequently Asked Questions on Genxai Analytics IPO GMP
What is the Genxai Analytics IPO GMP today on 5 June 2026?
Ans. The Genxai Analytics IPO GMP (grey market premium) today on 5 June 2026 is Rs 8 per share. Based on this GMP, the expected listing price for Genxai Analytics is approximately Rs 124 per share, which implies a potential listing gain of approximately 6.9% above the upper price band of Rs 116. The Genxai Analytics IPO GMP has fluctuated between Rs 8 and Rs 15 since the grey market opened, with Rs 8 as the level on June 4, 2026. Grey market premium is unofficial and unregulated; it should not be the sole basis for investment decisions.
What is the Genxai Analytics IPO price band and lot size?
Ans. The Genxai Analytics IPO price band is Rs 110 to Rs 116 per equity share with a face value of Rs 10 per share. The minimum lot size for the Genxai Analytics IPO is 1,200 shares. Retail investors are required to apply for a minimum of 2 lots (2,400 shares), making the minimum application amount Rs 2,78,400 at the upper price band of Rs 116. The Genxai Analytics IPO is an NSE SME issue and is therefore open only to investors who have a Demat account linked to an NSE-eligible broker.
When will Genxai Analytics IPO close and what are the key dates?
Ans. The Genxai Analytics IPO opened for subscription on June 5, 2026 and will close on June 9, 2026. The anchor investor allocation was conducted on June 4, 2026, when the company raised Rs 14.99 crore. The basis of allotment for the Genxai Analytics IPO is expected to be finalised on June 10, 2026. Shares will be credited to eligible investors’ Demat accounts on June 11, 2026. The tentative listing date for Genxai Analytics on the NSE SME (NSE Emerge) platform is June 12, 2026.
What does Genxai Analytics do and what is its business model?
Ans. Genxai Analytics Limited, incorporated in 2007, is a technology-driven enterprise performance and analytics solutions provider. The company offers AI-enabled workflow automation, enterprise planning (EPM), data engineering, analytics, application development, and Generative AI solutions to businesses across multiple industries. Its platforms help organisations streamline workflows, improve system performance, and enhance operational efficiency by integrating data across finance, sales, operations, customer management, and human resources into unified systems. As of March 31, 2026, the company employed 362 permanent employees. Choice Capital Advisors Pvt Ltd is the book running lead manager.
How should I evaluate the Genxai Analytics IPO GMP before applying?
Ans. The Genxai Analytics IPO GMP of Rs 8 (expected listing gain approximately 6.9%) represents mild grey market interest. For an SME IPO, a GMP of 7-10% is considered moderate and suggests cautious but positive market sentiment. However, investors should note that the Genxai Analytics IPO minimum investment is Rs 2,78,400 (2 lots), a significant sum for retail investors. Before applying for the Genxai Analytics IPO, investors should review the company’s FY26 financials, revenue growth trajectory, profitability, and the detailed risk factors in the Red Herring Prospectus filed on May 27, 2026. GMP alone should not drive investment decisions. This does not constitute investment advice.
